Drug susceptibility of a clinical isolate of Balamuthia mandrillaris , a pathogenic free-living amoeba
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.01482-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Pratima Dubey und 6 weiteren Autor:innen. Beteiligte Einrichtung: Siriraj Integrative Center for Neglected Parasitic Diseases (SiCNPD), Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol Unive…. Hauptthemen laut MEDLINE: Balamuthia mandrillaris, Antiprotozoal Agents, Amebicides. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mahidol University, National Research Council of Thailand.
Abstract (Originalsprache)
Balamuthia amoebic encephalitis (BAE) is a highly fatal infection caused by Balamuthia mandrillaris , an amoeba that lives in soil and water. In Thailand, three fatal cases of BAE have been documented, but no survivors have been reported, raising questions about current treatment regimens. Previous drug repurposing studies reveal some potent pharmacological compounds, but the drug susceptibility of the clinical isolate of pathogenic amoeba remains variable. Given the success in isolating B. mandrillaris from the human biopsied brain, this study aims to assess the amoebicidal effect of several previously repurposed drugs and suggested therapies for BAE. The trophozoites of a new clinical isolate, the KM-20 strain, were exposed to 12 compounds, including pentamidine, the most widely used antiprotozoal drug, and nitroxoline, the recent radical cure for BAE. The amoebicidal effect was assessed using the ATP level as a cell survival biomarker. The circularity and surface area of the cells were used as recrudescence indicators. Among all drugs tested, nitroxoline is the most potent amoebicidal drug without recrudescence. Topical antiseptic agents caused amoeba lysis at all doses tested, suggesting potential use for cutaneous balamuthiasis. Compared with two laboratory-adapted V039 and PRA-291 strains, the KM-20 isolate had reduced drug susceptibility to all of the tested compounds, suggesting strain dependency of amoebicidal activity. This study provides drug susceptibility data against a novel and geographically diverse clinical isolate of B. mandrillaris to assist in prioritizing anti- Balamuthia agents for further drug development testing, followed by in vivo efficacy testing animal models before clinical trials and drug repurposing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Siriraj Integrative Center for Neglected Parasitic Diseases (SiCNPD), Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Siriraj-Long Read Lab, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- College of Veterinary Medicine, Department of Comparative Pathobiology, Purdue University, West Lafayette, Indiana, USA.
- Purdue Institute for Drug Discovery (PIDD), Purdue University, West Lafayette, Indiana, USA.
- Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D), Purdue University, West Lafayette, Indiana, USA.
- Regenstrief Center for Healthcare Engineering (RCHE), Purdue University, West Lafayette, Indiana, USA.
ORCID-Profile: Porntida Kobpornchai, Chenyang Lu, Christopher A Rice, Kasem Kulkeaw
Förderung
- Mahidol University
- National Research Council of Thailand
Zitieren
APA
Dubey, P., Kobpornchai, P., Tongkrajang, N., Chaiyaloom, S., Lu, C., Rice, C. A., & Kulkeaw, K. (2026). Drug susceptibility of a clinical isolate of Balamuthia mandrillaris , a pathogenic free-living amoeba. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01482-25
Vancouver
Dubey P, Kobpornchai P, Tongkrajang N, Chaiyaloom S, Lu C, Rice CA, et al. Drug susceptibility of a clinical isolate of Balamuthia mandrillaris , a pathogenic free-living amoeba. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.01482-25
BibTeX
@article{Dubey2026,
author = {Dubey, Pratima and Kobpornchai, Porntida and Tongkrajang, Nongnat and Chaiyaloom, Suwipa and Lu, Chenyang and Rice, Christopher A and Kulkeaw, Kasem},
title = {Drug susceptibility of a clinical isolate of Balamuthia mandrillaris , a pathogenic free-living amoeba},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.01482-25}
}
EUVIMED